FDA Drug Recalls

Recalls / Class II

Class IID-1661-2012

Product

Leflunomide tablets, 10 mg, a) 30-count bottle (NDC 60505-2502-1), b) 1000-count bottle (NDC 60505-2502-3), Rx only, Manufactured for Apotex Corp., Weston, Florida 33326 by Apotex Inc., Toronto, Ontario Canada M9L 1T9

Brand name
Leflunomide
Generic name
Leflunomide
Active ingredient
Leflunomide
Route
Oral
NDCs
60505-2502, 60505-2503
FDA application
ANDA077090
Affected lot / code info
Lot #: a) GY4197, Exp 11/07; b) GZ1273, Exp 11/07.

Why it was recalled

Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.

Recalling firm

Firm
Apotex Corp.
Notification channel
FAX
Type
Voluntary: Firm initiated
Address
2400 N Commerce Pkwy, Ste 400, Weston, Florida 33326-3253

Distribution

Quantity
3063
Distribution pattern
Nationwide.

Timeline

Recall initiated
2007-06-14
FDA classified
2012-08-27
Posted by FDA
2012-09-05
Terminated
2012-08-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1661-2012. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Leflunomide · FDA Drug Recalls